FebriDx ® : A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
AbstractFebriDx® is a rapid, point-of-care diagnostic test that is designed to aid in the differentiation of bacterial and viral acute respiratory infections (ARIs), thus helping to guide decisions regarding the prescription of antibiotics in the outpatient setting. FebriDx carries a CE mark for use in the EU and is also approved in several other countries, including Canada, Saudi Arabia and Singapore. It is indicated for use in patients> 2 years old with symptoms consistent with a community-acquired ARI. The test involves the use of an immunoassay on a fingerstick blood sample to provide simultaneous, qualitative measurement of elevated levels of C-reactive protein (CRP) and myxovirus resistance protein A (MxA). In two prospecti ve, multicentre studies in patients with acute upper respiratory tract infections, FebriDx was shown to be both sensitive and specific in identifying patients with a clinically significant infection and in differentiating between infections of bacterial and viral aetiology. The test is simple, requi res no additional equipment and produces actionable results in ~ 10 min. As was demonstrated in a small, retrospective analysis, FebriDx results can help guide (improve) antibiotic prescribing decisions. Reducing the unnecessary or inappropriate prescription of antibiotics for ARIs of probable vi ral aetiology is important for antibiotic stewardship and can also reduce the unnecessary exposure of patients to the risk of ant...
Publication date: Available online 10 July 2020Source: Mutation Research/Genetic Toxicology and Environmental MutagenesisAuthor(s): V. Saravanan, S.S. Murugan, T.S. Kumaravel
Publication date: June–July 2020Source: Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Volumes 854–855Author(s):
Publication date: Available online 10 July 2020Source: Trends in GeneticsAuthor(s): David S. Wendler
Publication date: Available online 11 July 2020Source: Gene Expression PatternsAuthor(s): Roberto Rodríguez-Morales, Viveca Vélez-Negrón, Aranza Torrado-Tapias, Gaurav Varshney, Martine Behra
Publication date: Available online 10 July 2020Source: Revista Clínica Española (English Edition)Author(s): J.J. Hijona Elósegui, A.L. Carballo García, A.C. Fernández Risquez, M. Bermúdez Quintana, J.F. Expósito Montes
In this study, cynomolgus macaque UGT3A1, UGT3A2, and UGT8A1 cDNAs were isolated and characterized. Amino acid sequences deduced from cynomolgus UGT3A1, UGT3A2, and UGT8A1 cDNAs were highly identical with their human orthologs (93, 96, and 99%, respectively) and were closely clustered in a phylogenetic tree. In the genome, cynomolgus UGT3A and UGT8A genes were located in the regions corresponding to those of their human orthologs. Among the 10 tissue types analyzed, expression of cynomolgus UGT3A1 and UGT3A2 mRNAs was detected in liver, kidney, and testis; the UGT3A1 and UGT3A2 mRNAs were most abundant in liver and testis,...
Publication date: October 2020Source: Safety Science, Volume 130Author(s): Fei Tang, Zunxin Zhao, Kun Zhao
Publication date: Available online 10 July 2020Source: Safety ScienceAuthor(s): Paul Lindhout, Genserik Reniers
Publication date: Available online 11 July 2020Source: Safety and Health at WorkAuthor(s): Saija Hyvönen, Jouni Lohi, Tamara Tuuminen
Publication date: November 2020Source: Urology Case Reports, Volume 33Author(s): Gina T. Baaklini, Misty J. Thompson, Kevin J. Krauland, Daniel R. Walker, Steven J. Hudak